EAGLE PHARMACEUTICALS, INC.【EGRX】Income statement

Market cap

$14.29K

P/E ratio

	2014/09	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12
Revenue	19	66	189	237	213	196	188	172	317
Revenue growth (%)	-
Cost of revenue	12	16	34	34	42	48	34	32	85
Research & development	17	28	30	33	44	37	31	51	34
Selling, general & administrative	9	20	52	71	61	76	79	75	107
Operating margin (%)
Operating expenses	38	64	136	163	177	174	155	169	236
Operating income	-19	3	53	74	37	22	33	3	81
Income before tax	-19	3	53	73	34	22	23	-5	61
Pretax margin (%)	-100.9	3.9	28.2	30.8	16	11.2	12.1	-2.7	19.4
Provision for income taxes	-1	0	-28	21	2	8	11	4	26
Effective tax rate (%)
Net income	-18	3	81	52	32	14	12	-9	36
Net income margin (%)
Earnings per share	-	0.17	5.24	3.44	2.16	1.04	0.89	-0.66	2.76
Diluted EPS	-	0.16	4.96	3.27	2.09	1.01	0.87	-0.66	2.73